NB Health Laboratory Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $7.58M

  • Investors
  • 9

NB Health Laboratory General Information

Description

Operator of a biotechnology company intended for discovering, developing, and commercializing innovative medicines to treat respiratory diseases. The company's expertise is in the generation of functional antibodies targeting G protein-coupled receptors and it is pioneering a new field in targeted drug discovery, enabling medical researchers to improve chronic inflammation and central nervous system disorders in patients.

Contact Information

Website
www.nbhl.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hokkaido Industry-Academia-Government Collaboration Center
  • Kita 21-jo Nishi 12-chome, Kita-Ku
  • Sapporo, Hokkaido 001-0021
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Hokkaido Industry-Academia-Government Collaboration Center
  • Kita 21-jo Nishi 12-chome, Kita-Ku
  • Sapporo, Hokkaido 001-0021
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NB Health Laboratory Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 27-Apr-2022 $7.58M Completed Pre-Clinical Trials
4. Accelerator/Incubator 24-Dec-2020 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Mar-2020 Completed Pre-Clinical Trials
2. Later Stage VC 31-May-2018 $3.28M $5.21M Completed Pre-Clinical Trials
1. Seed Round 28-Oct-2016 $1.93M $1.93M Completed Pre-Clinical Trials
To view NB Health Laboratory’s complete valuation and funding history, request access »

NB Health Laboratory Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred C
Preferred B
Preferred A 1,250 $1276.06 $1276.06 1x $1276.06 13.65%
To view NB Health Laboratory’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NB Health Laboratory Patents

NB Health Laboratory Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026035669-A Antibody, nucleic acid, cell, and medicament Pending 31-Jan-2024
EP-4692121-A1 Antibody, nucleic acid, cell and drug Pending 28-Mar-2023
JP-2025183331-A Antibody, nucleic acid, cell, and pharmaceutical Pending 28-Mar-2023
EP-4606896-A1 Antibody, nucleic acid, cell, and pharmaceutical Pending 18-Oct-2022
JP-2024170469-A Antibody, nucleic acid, cell, and pharmaceutical Pending 18-Oct-2022 C07K16/28
To view NB Health Laboratory’s complete patent history, request access »

NB Health Laboratory Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NB Health Laboratory Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Healthcare Innovation Venture Capital Minority
Trinity Innovation Fund Venture Capital Minority
FASTAR Accelerator/Incubator
Startup Hokkaido Accelerator/Incubator
Anniversaire Holdings Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

NB Health Laboratory FAQs

  • When was NB Health Laboratory founded?

    NB Health Laboratory was founded in 2006.

  • Where is NB Health Laboratory headquartered?

    NB Health Laboratory is headquartered in Sapporo, Japan.

  • What is the size of NB Health Laboratory?

    NB Health Laboratory has 20 total employees.

  • What industry is NB Health Laboratory in?

    NB Health Laboratory’s primary industry is Drug Discovery.

  • Is NB Health Laboratory a private or public company?

    NB Health Laboratory is a Private company.

  • What is the current valuation of NB Health Laboratory?

    The current valuation of NB Health Laboratory is .

  • What is NB Health Laboratory’s current revenue?

    The current revenue for NB Health Laboratory is .

  • How much funding has NB Health Laboratory raised over time?

    NB Health Laboratory has raised $12.8M.

  • Who are NB Health Laboratory’s investors?

    Healthcare Innovation, Trinity Innovation Fund, FASTAR, Startup Hokkaido, and Anniversaire Holdings are 5 of 9 investors who have invested in NB Health Laboratory.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process